GlassScriptPhysician profile
Davut Cekmecelioglu
NPI 1538729462
$3,674.41
in general payments reported to CMS, 2019-2025
10 companies · $1,942 in 2025
The $1,942 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $760 · 2024: $972 · 2025: $1,942.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,660 · Travel and Lodging: $14.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,659.70 |
| Travel and Lodging | $14.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $901.53 | 2024-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2) |
| Corcym INC | $682.60 | 2023-2025 | Perceval, Memo 4d |
| Edwards Lifesciences Corporation | $601.15 | 2023-2025 | Inspiris Resilia Aortic Valve, Sapien 3 Ultra Resilia |
| Dilon Technologies, INC. | $553.76 | 2023-2025 | Hemoblast Bellows |
| Bolton Medical INC | $370.13 | 2023-2025 | Relay Thoracic Stent-Graft With Plus Delivery System, Thoraflex Hybrid |
| Stryker Corporation | $173.47 | 2025 | Spy-Phi System |
| Hemosonics LLC | $136.04 | 2023 | Quantra Qplus System |
| Abiomed | $127.29 | 2023 | Impella |
| Baxter Healthcare | $110.45 | 2024 | Preveleak |
| Medtronic, INC. | $17.99 | 2023 | Corevalve Evolut R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Davut Cekmecelioglu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.